Why the study?
Does posterior pericardiotomy prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
Does posterior pericardiotomy prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
This editorial discusses the PALACS trial, which evaluated posterior pericardiotomy for preventing postoperative atrial fibrillation after cardiac surgery.
During the American Heart Association Scientific Sessions 2021, Dr Mario Gaudino presented the results of the PALACS (Posterior Left pericardiotomy for the prevention of postoperative Atrial fibrillation after Cardiac Surgery) trial, which were simultaneously published in The Lancet.1 This trial attracted attention to posterior pericardiotomy (PP)—an intervention first applied in cardiac surgery a quarter-century ago,2 whose mechanism of action is linked to the elimination of pericardial effusion—a known trigger of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Kaleda et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: